Related Experiment Video

Updated: Sep 23, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Nevirapine use in HIV-1-infected children

Gwenda Verweel1, Mike Sharland, Hermione Lyall

  • 1Imperial College, London, UK.

AIDS (London, England)
|July 11, 2003
PubMed

Insights

Nevirapine showed good tolerability and clinical benefits in children with HIV-1. Higher doses than recommended improved viral load suppression, suggesting potential for optimized combination antiretroviral therapy (ART).

Area of Science:

  • Pediatric infectious diseases
  • Virology
  • Immunology

Background:

  • Human Immunodeficiency Virus type 1 (HIV-1) infection in children requires effective combination antiretroviral therapy (ART).
  • Nevirapine is a non-nucleoside reverse transcriptase inhibitor used in ART regimens.
  • Evaluating nevirapine's role in pediatric HIV-1 management is crucial for optimizing treatment outcomes.

Purpose of the Study:

  • To assess the safety and efficacy of nevirapine in HIV-1-infected children.
  • To evaluate clinical, virological, and immunological responses to nevirapine-based ART.
  • To explore optimal dosing strategies for nevirapine in pediatric populations.

Main Methods:

  • Retrospective review of case notes for HIV-1-infected children receiving nevirapine.
  • Data collected over 96 weeks from a national compassionate access scheme in the UK.
  • Nevirapine dosing followed manufacturer guidelines, with analysis of outcomes at different dose levels.

Main Results:

  • Nevirapine was well tolerated in 74 children (median age 5.2 years).
  • Significant increases in CD4 cell count percentages and weight/height Z-scores were observed.
  • Higher nevirapine doses (>300 mg/m2/day) correlated with improved viral load suppression (60% undetectable vs. 17% at recommended doses).

Conclusions:

  • Nevirapine demonstrated good tolerability and positive clinical/immunological effects in children.
  • Virological data suggest that doses exceeding current manufacturer recommendations may enhance treatment efficacy.
  • Findings support further investigation into higher nevirapine dosing for improved outcomes in pediatric HIV-1 management.
Abstract

More Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

Related Concept Videos

Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...